Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: Prevalence of thrombosis in a 1 year follow-up

Italian Heart Journal

Volumn 1, Issue 1, 2000, Pages 39-42

  Mattioli, A V ^a   Bonetti, L ^a   Sternieri, S ^a   Mattioli, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Heparin induced thrombocytopenia; IgG antibodies; Thrombosis; Unfractionated heparin

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RECURRENT DISEASE; REVASCULARIZATION; STROKE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTIBODIES, ANTI-IDIOTYPIC; ANTICOAGULANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMAN; IMMUNOGLOBULIN G; MALE; MIDDLE AGE; PLATELET FACTOR 4; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0033781245     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Heparin induced thrombocytopenia: Toward consensus
2. Heparin-induced thrombocytopenia
3. Heparin-induced thrombocytopenia: Association with thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation
4. Prevalence of heparin associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery
5. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases
6. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin-platelet factor 4 complexes
7. Heparin-associated thrombocytopenia
8. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
9. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis
10. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tiofibran in unstable angina and non-Q wave myocardial infarction. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms Study Investigators